ArticleAnnals of Indian Academy of Neurology2026
Status Dystonicus: An Updated Review on Diagnosis, Pathophysiology, and Management.
Article in Annals of Indian Academy of Neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Status dystonicus (SD), also called dystonic storm or dystonic crisis historically, represents a rare and life-threatening exacerbation of dystonia characterized by continuous (tonic) or phasic rapidly recurring dystonic spasms. Common triggers include infections, abrupt changes in medication, and metabolic stress, among others, and necessitate early recognition with multidisciplinary management to prevent multisystemic failure or dysfunction. SD arises in patients with generalized dystonia, more commonly in those with secondary causes, and is associated with basal ganglia dysfunction and predominantly dopaminergic disturbances. The Dystonia Severity Action Plan is a widely accepted staging tool that requires bedside assessment and helps inform therapeutic decisions and intervention levels. Management principles center on identifying and removing triggers, optimizing sedation and airway management, and administering disease-specific therapies. The review aims to provide an overview of the clinical spectrum, the physiological basis, commonly described precipitating factors, and updated management strategies for SD, highlighting a practical approach to the early identification of the syndrome and the bundling of care. A narrative review of peer-reviewed literature from PubMed and Scopus databases was conducted, with emphasis on publications covering etiopathogenesis, risk factors, clinical grading systems, therapeutic options, and outcomes. Key consensus guidelines and case series were appraised. It is evident that early diagnosis and triage, with adequate management, are key to improving survival and neurological outcomes in SD. Adoption of standardized clinical pathways and multicenter data reports will help improve understanding of SD's natural history, clinical evaluation, and therapeutic efficacy across different etiologies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.